Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids

Open access
Fountas, Athanasios, Chai, Shu Teng, Kourkouti, Chrysoula, Karavitaki, Niki · 2018 · European Journal of Endocrinology

Abstract

The use of opioids has grown substantially over the past two decades reaching the dimensions of a global epidemic. These drugs have effects on multiple levels of the endocrine system through mechanisms which are still not fully elucidated, and awareness of their endocrine sequelae is vital for all specialists prescribing or managing patients on them. Hypogonadism is the most well-recognised consequence of opioid use (prevalence 21–86%) which, however, may remain undiagnosed with potential adverse outcomes for the patients. Although less frequent, cortisol deficiency can also be found. Furthermore, there is a negative impact on bone health (with reduced bone mineral density and increased fracture risk) and occasionally hyperprolactinaemia, whereas the clinical significance of alterations in other hormones remains to be clarified. Discontinuation or reduction of the opioid and, in cases of chronic pain, consideration of alternative therapies for pain relief are potential management options. Hormonal replacement, especially when the above measures are not practically feasible, needs to be considered. Further studies are needed to clearly establish the prevalence of hormonal abnormalities with various regimes, doses and routes of opioids and to address reliably the long-term benefits and risks of hormonal treatment in patients on opioids. Until evidence-based, safe and cost-effective clinical guidelines become available, periodical assessment of the gonadal and adrenal function (particularly when relevant clinical manifestations are present) and evaluation of the bone health status are advised.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-18-0270

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 126 references

Research works printed but not linked: 125

  1. 2013, Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients, Neuropsychobiology, 67, 111, 10.1159/000346110 · DOI · Paper page
  2. 2005, Bone mineral density in subjects using central nervous system-active medications, American Journal of Medicine, 118, 1414
  3. 2006, Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency, Journal of Pain, 7, 200, 10.1016/j.jpain.2005.10.009 · DOI · Paper page
  4. 1974, Galactorrhea-amenorrhea syndrome associated with heroin addiction, American Journal of Obstetrics and Gynecology, 118, 966, 10.1016/0002-9378(74)90667-X · DOI · Paper page
  5. 2014, High-dose remifentanil suppresses stress response associated with pneumoperitoneum during laparoscopic colectomy, Journal of Anesthesia, 28, 334, 10.1007/s00540-013-1738-x · DOI
  6. 2003, Effects of systemic and epidural morphine on antidiuretic hormone levels in children, Paediatric Anaesthesia, 13, 508, 10.1046/j.1460-9592.2003.01096.x · DOI · Paper page
  7. 2006, The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress, Neuropsychopharmacology, 31, 204, 10.1038/sj.npp.1300856 · DOI
  8. 2015, Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase, Psychoneuroendocrinology, 52, 59, 10.1016/j.psyneuen.2014.10.013 · DOI
  9. 1996, Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone, Endocrine Practice, 2, 4, 10.4158/EP.2.1.4 · DOI
  10. 2015, Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients, Pain Medicine, 16, 715, 10.1111/pme.12661 · DOI · Paper page
  11. 2010, The effects of opioids and opioid analogs on animal and human endocrine systems, Endocrine Reviews, 31, 98, 10.1210/er.2009-0009 · DOI · Paper page
  12. 1984, Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF), Endocrinology, 114, 1950, 10.1210/endo-114-5-1950 · DOI · Paper page
  13. 2006, DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production, Journal of Pain, 7, 901, 10.1016/j.jpain.2006.04.011 · DOI
  14. 1998, Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male, Hormone and Metabolic Research, 30, 34, 10.1055/s-2007-978827 · DOI
  15. 2010, Changes in metabolic-related variables during chronic morphine treatment, Neurochemistry International, 57, 323, 10.1016/j.neuint.2010.06.011 · DOI
  16. 2016, Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats, Advanced Biomedical Research, 5, 21, 10.4103/2277-9175.175907 · DOI
  17. 2014, Changes in trends and pattern of strong opioid prescribing in primary care, European Journal of Pain, 18, 1343, 10.1002/j.1532-2149.2014.496.x · DOI · Paper page
  18. 1994, Multiple opiate receptor subtypes are involved in the stimulation of growth hormone release by beta-endorphin in female rats, Neuroendocrinology, 60, 69, 10.1159/000126721 · DOI
  19. 1985, Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor, Neuroendocrinology, 41, 13, 10.1159/000124147 · DOI · Paper page
  20. 1989, Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro, Endocrinology, 124, 2330, 10.1210/endo-124-5-2330 · DOI
  21. 1986, Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man, Neuroendocrinology, 42, 357, 10.1159/000124463 · DOI
  22. 2008, Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain, Journal of Pain, 9, 28, 10.1016/j.jpain.2007.08.005 · DOI · Paper page
  23. 2016, Adrenal insufficiency in patients on long-term opioid analgesia, Clinical Endocrinology, 85, 831, 10.1111/cen.13125 · DOI · Paper page
  24. 2005, Enhanced prolactin levels in opium smokers, Addiction Biology, 10, 345, 10.1080/13556210500351263 · DOI · Paper page
  25. 1979, Effects of heroin addiction on thyrotrophin, thyroid hormones and porlactin secretion in men, Clinical Endocrinology, 10, 557, 10.1111/j.1365-2265.1979.tb02115.x · DOI
  26. 1984, Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts, Acta Endocrinologica, 105, 149, 10.1530/acta.0.1050149 · DOI · Paper page
  27. 2002, Sex hormone suppression by intrathecal opioids: a prospective study, Clinical Journal of Pain, 18, 144, 10.1097/00002508-200205000-00002 · DOI
  28. 2007, Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment, Clinical Endocrinology, 66, 604, 10.1111/j.1365-2265.2007.02779.x · DOI · Paper page
  29. 1987, Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects, Metabolism: Clinical and Experimental, 36, 105, 10.1016/0026-0495(87)90001-1 · DOI
  30. 1985, Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function, Hormone Research, 21, 155, 10.1159/000180040 · DOI · Paper page
  31. 2013, Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone, Addiction Biology, 18, 325, 10.1111/j.1369-1600.2011.00313.x · DOI
  32. 1980, Effects of chronic heroin addiction on pituitary-thyroid function in man, Journal of Endocrinological Investigation, 3, 251, 10.1007/BF03348271 · DOI · Paper page
  33. 2015, Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans, Psychoneuroendocrinology, 52, 281, 10.1016/j.psyneuen.2014.12.004 · DOI
  34. 2011, Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction, Pain Research and Management, 16, 311, 10.1155/2011/807123 · DOI · Paper page
  35. 2012, Basic opioid pharmacology: an update, British Journal of Pain, 6, 11, 10.1177/2049463712438493 · DOI · Paper page
  36. 1987, Effects of fentanyl on vasopressin secretion in human subjects, Journal of Pharmacology and Experimental Therapeutics, 242, 970, 10.1016/S0022-3565(25)39200-1 · DOI · Paper page
  37. 2006, Fracture risk associated with the use of morphine and opiates, Journal of Internal Medicine, 260, 76, 10.1111/j.1365-2796.2006.01667.x · DOI · Paper page
  38. 2015, Opioid receptors, BJA Education, 15, 219, 10.1093/bjaceaccp/mku041 · DOI
  39. 1975, Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man, Journal of Clinical Endocrinology and Metabolism, 41, 797, 10.1210/jcem-41-4-797 · DOI · Paper page
  40. 1975, Function of the male sex organs in heroin and methadone users, New England Journal of Medicine, 292, 882, 10.1056/NEJM197504242921703 · DOI · Paper page
  41. 1994, Altered sexual function and decreased testosterone in patients receiving intraspinal opioids, Journal of Pain and Symptom Management, 9, 126, 10.1016/0885-3924(94)90166-X · DOI
  42. 2005, Chronic fentanyl application induces adrenocortical insufficiency, Journal of Internal Medicine, 257, 478, 10.1111/j.1365-2796.2005.01483.x · DOI · Paper page
  43. 2015, Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial, Pain, 156, 280, 10.1097/01.j.pain.0000460308.86819.aa · DOI · Paper page
  44. 2016, Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency, Clinical Endocrinology, 85, 232, 10.1111/cen.13049 · DOI · Paper page
  45. 1975, Plasma testosterone levels in heroin addiction and during methadone maintenance, Journal of Pharmacology and Experimental Therapeutics, 192, 211, 10.1016/S0022-3565(25)30047-9 · DOI
  46. 2012, The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence, European Addiction Research, 18, 116, 10.1159/000334411 · DOI
  47. 1993, Effects of chronic heroin abuse on bone and mineral metabolism, Acta Endocrinologica, 129, 42, 10.1530/acta.0.1290042 · DOI
  48. 1984, Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neuroendocrinology, 38, 411, 10.1159/000123927 · DOI · Paper page
  49. 2015, Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia, Endocrinology Diabetes and Metabolism Case Reports, 2015, 150035
  50. 1982, A new Met-enkephalin analogue suppresses plasma vasopressin in man, Peptides, 3, 199, 10.1016/0196-9781(82)90051-1 · DOI
  51. 2006, Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity, Psychoneuroendocrinology, 31, 642, 10.1016/j.psyneuen.2006.02.003 · DOI · Paper page
  52. 2013, Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy, BMJ Open, 3, e002856, 10.1136/bmjopen-2013-002856 · DOI · Paper page
  53. 2014, Elucidating risk factors for androgen deficiency associated with daily opioid use, American Journal of Medicine, 127, 1195, 10.1016/j.amjmed.2014.07.015 · DOI · Paper page
  54. 2009, Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women, Experimental and Clinical Endocrinology and Diabetes, 117, 38
  55. 2003, Patients with chronic pain and abnormal pituitary function require investigation, Lancet, 361, 2203, 10.1016/S0140-6736(03)13775-0 · DOI · Paper page
  56. 2011, Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients, Reproductive Biology and Endocrinology, 9, 26, 10.1186/1477-7827-9-26 · DOI · Paper page
  57. 1982, The roles of opioid peptides in controlling thyroid stimulating hormone release, Life Sciences, 31, 2529, 10.1016/0024-3205(82)90760-3 · DOI
  58. 2012, Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project, Psychoneuroendocrinology, 37, 1922, 10.1016/j.psyneuen.2012.04.006 · DOI
  59. 2014, Adrenal insufficiency in acute oral opiate therapy, Endocrinology Diabetes and Metabolism Case Reports, 2014, 130071
  60. 2004, Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids, Cancer, 100, 851, 10.1002/cncr.20028 · DOI · Paper page
  61. 2004, Opioid osteoporosis, Archives of Internal Medicine, 164, 338
  62. 1986, Alteration of pulsatile growth hormone secretion by growth-inducing exercise: involvement of endogenous opiates and somatostatin, Endocrinology, 118, 844, 10.1210/endo-118-2-844 · DOI
  63. 1989, Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis, Journal of Rheumatology, 19, 154
  64. 1988, Involvement of the hypothalamus in opiate-stimulated prolactin secretion, Regulatory Peptides, 20, 305, 10.1016/0167-0115(88)90065-1 · DOI
  65. consequences of opioid therapy Supplement https org, Psychoneuroendocrinology, 1
  66. 1996, Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat, Life Sciences, 59, 1881, 10.1016/S0024-3205(96)00535-8 · DOI
  67. 1975, Mechanism of action of narcotics in the production of menstrual dysfunction in women, Fertility and Sterility, 26, 538, 10.1016/S0015-0282(16)41173-8 · DOI
  68. 1991, Effects of morphine on the pituitary-thyroid axis: morphological and analytical studies, Functional and Developmental Morphology, 1, 3
  69. 2016, Prescription of long-acting opioids and mortality in patients with chronic noncancer pain, JAMA, 315, 2415, 10.1001/jama.2016.7789 · DOI · Paper page
  70. 1986, Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man, Hormone and Metabolic Research, 18, 842, 10.1055/s-2007-1012453 · DOI
  71. 2016, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism, 101, 3888, 10.1210/jc.2016-2118 · DOI · Paper page
  72. 2005, Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence, Journal of Clinical Endocrinology and Metabolism, 90, 203, 10.1210/jc.2004-0929 · DOI · Paper page
  73. 2011, Decreased bone density in men on methadone maintenance therapy, Addiction, 106, 349, 10.1111/j.1360-0443.2010.03159.x · DOI · Paper page
  74. 2016, Opioid receptors, Annual Review of Medicine, 67, 433, 10.1146/annurev-med-062613-093100 · DOI · Paper page
  75. 2015, Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial, Psychoneuroendocrinology, 56, 157, 10.1016/j.psyneuen.2015.03.015 · DOI · Paper page
  76. 2015, Testosterone suppression in opioid users: a systematic review and meta-analysis, Drug and Alcohol Dependence, 149, 1, 10.1016/j.drugalcdep.2015.01.038 · DOI · Paper page
  77. 1988, Gonadal function in male heroin and methadone addicts, International Journal of Andrology, 11, 93, 10.1111/j.1365-2605.1988.tb00984.x · DOI · Paper page
  78. 2000, Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose, Psychopharmacology, 150, 253, 10.1007/s002130000413 · DOI
  79. 1985, Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects, Journal of Clinical Endocrinology and Metabolism, 60, 891, 10.1210/jcem-60-5-891 · DOI · Paper page
  80. 2011, Stimulatory effect of naloxone on plasma cortisol in human: possible direct stimulatory action at the adrenal cortex, Regulatory Peptides, 166, 1, 10.1016/j.regpep.2010.08.008 · DOI
  81. 1989, Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone, Journal of Clinical Endocrinology and Metabolism, 69, 356, 10.1210/jcem-69-2-356 · DOI · Paper page
  82. 1983, Endocrine effects of methadone in rats; acute effects in adults, European Journal of Pharmacology, 95, 231, 10.1016/0014-2999(83)90639-8 · DOI
  83. 2000, Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man, British Journal of Clinical Pharmacology, 50, 227, 10.1046/j.1365-2125.2000.00256.x · DOI · Paper page
  84. 1983, The participation of hypothalamic dopamine in morphine-induced prolactin release in man, Clinical Endocrinology, 19, 437, 10.1111/j.1365-2265.1983.tb00017.x · DOI
  85. 2002, Hypogonadism in men consuming sustained-action oral opioids, Journal of Pain, 3, 377, 10.1054/jpai.2002.126790 · DOI · Paper page
  86. 1976, Effects of acetylmethadol on plasma testosterone, Clinical Pharmacology and Therapeutics, 19, 371, 10.1002/cpt1976193371 · DOI · Paper page
  87. 1982, Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women, Fertility and Sterility, 37, 389, 10.1016/S0015-0282(16)46101-7 · DOI
  88. 1992, Opiate modulation of growth hormone secretion is compromised during the steroid-induced luteinizing hormone surge, Neuroendocrinology, 55, 214, 10.1159/000126117 · DOI
  89. 1985, Morphine-induced TSH release in normal and hypothyroid subjects, Neuroendocrinology, 40, 303, 10.1159/000124091 · DOI · Paper page
  90. 2014, Chronic heroin dependence leading to adrenal insufficiency, Case Reports in Endocrinology, 2014, 461816
  91. 1987, Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone, Acta Endocrinologica, 114, 509, 10.1530/acta.0.1140509 · DOI
  92. 2005, Effect of opiates on growth hormone secretion in acromegaly, Hormone and Metabolic Research, 37, 425, 10.1055/s-2005-870230 · DOI · Paper page
  93. 2003, Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy, Journal of Pain and Symptom Management, 26, 1055, 10.1016/S0885-3924(03)00331-2 · DOI
  94. 1991, Changes in growth hormone and luteinizing hormone following acute or chronic administration of an opioid agonist, FK33-824, in wethers, Journal of Animal Science, 69, 774, 10.2527/1991.692774x · DOI
  95. 2010, Acute HPA axis response to naltrexone differs in female vs. male smokers, Psychoneuroendocrinology, 35, 596, 10.1016/j.psyneuen.2009.09.016 · DOI · Paper page
  96. 1972, Growth hormone in narcotic addiction, Journal of Clinical Endocrinology and Metabolism, 35, 352, 10.1210/jcem-35-3-352 · DOI · Paper page
  97. 1985, Effect of naloxone on the hormone response to CRF in normal man, Endocrine Research, 11, 39, 10.3109/07435808509035423 · DOI
  98. 1993, Effects of chronic stimulation or antagonism of opiate receptors on GH secretion in male and female rats, Life Sciences, 52, 1443, 10.1016/0024-3205(93)90068-E · DOI
  99. 2010, Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment, Clinical Journal of Pain, 26, 374, 10.1097/AJP.0b013e3181d1059d · DOI · Paper page
  100. 1998, Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism, Alcoholism, Clinical and Experimental Research, 22, 1430, 10.1111/j.1530-0277.1998.tb03931.x · DOI
  101. 1985, Hypothalamus-pituitary-adrenal axis of heroin addicts, Drug and Alcohol Dependence, 15, 361, 10.1016/0376-8716(85)90014-6 · DOI · Paper page
  102. 1984, Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal, Clinical Pharmacology and Therapeutics, 35, 545, 10.1038/clpt.1984.75 · DOI
  103. 1996, The steroidogenic effects of beta-endorphin and joining peptide: a potential role in the modulation of adrenal androgen production, Journal of Endocrinology, 151, 301, 10.1677/joe.0.1510301 · DOI
  104. 1998, Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain, Journal of Rheumatology, 25, 1374
  105. 2013, Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database, American Journal of Epidemiology, 178, 559, 10.1093/aje/kwt013 · DOI
  106. 1988, Hormone secretion in methadone-dependent and abstinent patients, NIDA Research Monograph, 81, 216
  107. 2011, Tramadol-induced adrenal insufficiency, European Journal of Clinical Pharmacology, 67, 865, 10.1007/s00228-011-0992-9 · DOI
  108. consequences of opioid therapy Supplement https org, Psychoneuroendocrinology, 1
  109. 1996, mu-Opioid agonists stimulate growth hormone secretion in immature rats, Neuroendocrinology, 63, 489, 10.1159/000127077 · DOI
  110. 2011, Opioid receptor subtypes: fact or artifact?, British Journal of Anaesthesia, 107, 8, 10.1093/bja/aer115 · DOI
  111. 1993, Effects of morphine and naloxone on prolactin and growth hormone gene expression in the male rat pituitary gland, Journal of Neuroendocrinology, 5, 553, 10.1111/j.1365-2826.1993.tb00521.x · DOI
  112. 1985, Effect of postoperative extradural morphine on ADH secretion, British Journal of Anaesthesia, 57, 407, 10.1093/bja/57.4.407 · DOI
  113. 2004, Opioid osteoporosis, Archives of Internal Medicine, 164, 338
  114. 2013, Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids, Clinical Journal of Pain, 29, 840, 10.1097/AJP.0b013e31827c7b5d · DOI
  115. ASIPP, safe and effective prescription of opioids for chronic non - cancer pain of Interventional Pain Physicians guidelines, American Society Pain Physician
  116. 1986, Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia, Canadian Anaesthetists Society Journal, 33, 475, 10.1007/BF03010974 · DOI · Paper page
  117. 2000, Endocrine consequences of long-term intrathecal administration of opioids, Journal of Clinical Endocrinology and Metabolism, 85, 2215, 10.1210/jcem.85.6.6615 · DOI · Paper page
  118. 1975, Plasma testosterone levels during chronic heroin use and protracted astinence. A study of Hong Kong addicts, Clinical Pharmacology and Therapeutics, 17, 529, 10.1002/cpt1975175529 · DOI · Paper page
  119. 1981, Opiate receptors modulate LHRH and SRIF release from mediobasal hypothalamic neurons, Neuroendocrinology, 32, 163, 10.1159/000123150 · DOI · Paper page
  120. 2017, Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis, Pain Medicine, 18, 637
  121. 2000, Hypogonadism in patients treated with intrathecal morphine, Clinical Journal of Pain, 16, 251, 10.1097/00002508-200009000-00011 · DOI · Paper page
  122. 2002, Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion, Pharmacotherapy, 22, 1188, 10.1592/phco.22.13.1188.33526 · DOI
  123. 1999, Neuroendocrine control of growth hormone secretion, Physiological Reviews, 79, 511, 10.1152/physrev.1999.79.2.511 · DOI · Paper page
  124. 2008, Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment, Journal of Sexual Medicine, 5, 684, 10.1111/j.1743-6109.2007.00702.x · DOI · Paper page
  125. 1996, Opioid receptor activation resets the hypothalamic clock generating growth hormone secretory bursts in the rat, Journal of Endocrinology, 148, 149, 10.1677/joe.0.1480149 · DOI

Cited by

See all 60

Metadata

Authors
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N.
Affiliations
University Hospitals Birmingham NHS Foundation Trust (GB)
Corresponding author
Karavitaki, Niki
Venue
European Journal of Endocrinology
Published
2018-10
Volume
179
Issue
4
Pages
R183-R196
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2811034727
Cited by
60
References
126
Citations by year
2026: 5 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 9
FWCI
1.41
Type
journal article
Language
en
Licence
other-oa
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
opioid use, hypogonadism, cortisol deficiency, bone mineral density, fracture risk, hyperprolactinemia, gonadal function, adrenal function, hormone replacement therapy, chronic pain, opioid epidemic
MeSH terms
Deprescriptions, Analgesics, Opioid, Bone Diseases, Metabolic, Fractures, Spontaneous, Humans, Hydrocortisone, Hyperprolactinemia, Hypogonadism, Opioid-Related Disorders, Risk Factors, Bone Density, Prevalence, Fractures, Bone, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids. https://app.cochat.ai/papers/10.1530/eje-18-0270
The paper
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018). MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids. European Journal of Endocrinology. https://doi.org/10.1530/eje-18-0270

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.